Nominations for the 2012 Stop TB Partnership-Kochon Prize are being accepted until 1 September 2012. Funded by the Kochon Foundation, a non-profit foundation registered in the Republic of Korea, the US$ 65 000 prize is awarded once a year to persons, institutions, or organizations that have made a highly significant contribution to combating tuberculosis (TB).

When: 14:30 – 16:30, Sunday 8 July 2012
Where: Peoples Health Assembly, The University of the Western Cape (UWC), Room TBA
Attendance open to all registered participants of the PHA

TBVI has opened the following Call for proposals:
Deadline:  17:00 CEST, 11 September 2012

The Southern Africa Treatment and Resistance Network (SATuRN) training programme invite you to participate in the 7th South African HIV & TB Drug Resistance and Treatment Monitoring Workshop. This workshop is funded in collaboration with the Free State Initiative on Resistance, Surveillance, and Treatment (FIRST) Study, a research project funded by European Union and the International Development Research Center (IDRC), the University of the Western Cape CDC/PEPFAR program, the Africa Centre/CAPRISA CDC program.

Seven pharmaceutical companies and four research institutions including Weill Cornell Medical College, working with the Bill & Melinda Gates Foundation, have launched an innovative partnership that aims to speed the discovery of essential new treatments for tuberculosis (TB).

A European team of scientists is working on making new tuberculosis treatments a reality by developing better diagnostic imaging technology. The study is supported by the PREDICT-TB ('Model-based preclinical development of anti-tuberculosis drug combinations') project, which has clinched almost EUR 14.8 million from the Innovative Medicines Initiative (IMI) under the EU's Seventh Framework Programme (FP7). IMI is a public-private partnership between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

The TB Europe Coalition organizes a symposium during the Union Regional Conference on Tuberculosis and Lung Diseases in London on 5 July from 2-5pm.

In a welcome development, the central government of India has prohibited the manufacture for sale, distribution and use of serodiagnostic test kits for diagnosis of tuberculosis (TB).

CAPE TOWN — QdotPharma, the only South African-owned clinical research organisation able to do "first in man" drug studies, has closed its doors, citing delays in project approvals by the Medicines Control Council (MCC).

Tuberculosis can be a serious threat to monkeys and apes.  A new technique for detecting the tuberculosis -causing bacteria could help in protecting the health of primate populations. The method can spot TB even among infected primates that show no outward sign of disease, but are still capable of spreading infection to others of their kind.